---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-000464"
form_type: "8-K"
ticker: "APUS"
cik: "0001894525"
company_name: "Apimeds Pharmaceuticals US, Inc."
filed_at: "2026-01-02T23:59:59+00:00"
generated_at: "2026-05-16T11:50:55.561231+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Apimeds Pharmaceuticals removes director Erik Emerson via stockholder vote

## Summary
- Erik Emerson removed from board of directors effective December 30, 2025.
- Removal effected by majority stockholder vote, with or without cause.
- Remaining board: Elona Kogan, Jakap Koo, Carol O'Donnell, Dr. Bennett Weintraub.

## SEC filing metadata
- accession: 0001213900-26-000464
- form_type: 8-K
- ticker: APUS
- cik: 0001894525
- company_name: Apimeds Pharmaceuticals US, Inc.
- filed_at: 2026-01-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894525/000121390026000464/0001213900-26-000464-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894525/000121390026000464/ea0271636-8k_apimeds.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-000464
- JSON: https://secwatch.observer/filing/0001213900-26-000464.json
- Plain text: https://secwatch.observer/filing/0001213900-26-000464.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.